Boston Area Anticoagulation Trial for Atrial Fibrillation (BAATAF)


Phase 3 Results

Summary of Purpose

To determine the benefits and risks of oral anticoagulant therapy in reducing embolic stroke and systemic emboli in patients with atrial fibrillation without rheumatic heart disease.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 9 April 2014.

1 Jul 1985 27 Oct 1999 1 Jun 1991 1 Jun 1991 1 Apr 2014 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Purpose: Prevention


Not available